業績

2021年

2020年

2019年

2018年

2017年

2016年

2015年

2014年

2013年

2012年

2011年

2021年

論文
  1. Koguchi-Yoshioka H, Watanabe R*, Matsumura Y, Ishitsuka Y, Inoue S, Furuta J, Nakamura Y, Okiyama N, Matsuzaka T, Shimano H, Fujisawa Y, Fujimoto M. Serum lactate dehydrogenase level as a possible predictor of treatment preference in psoriasis. J Dermatol Sci. 2021 Jul 22
  2. Tanaka R, Ichimura Y, Kubota N, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Mizuno S, Takahashi S, Fujimoto M, Okiyama N*. Differential involvement of programmed cell death ligands in skin immune responses. J Invest Dermatol. 2021 Jul 23
  3. Iijima A, Kanemaru K, Wang Y, Nabekura T, Nakamura Y, Fujisawa Y, Mori D, Ohmuraya M, Yamasaki S, Tahara-Hanaoka S, Shibuya A*. Corrigendum to selective expression of a C-type lectin receptor, Clec12b, on skin mast cells. Biochem Biophys Res Commun. 2021 Jul 7
  4. Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S.  Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jul 1;3(7):E489-E497.
  5. Yoneda K*, Kubo A, Nomura T, Ishida-Yamamoto A, Suga Y, Akiyama M, Kanazawa N, Hashimoto T; Committee on Guidelines for the Management of PPKs. Japanese guidelines for the management of palmoplantar keratoderma. J Dermatol. 2021 Jun 13
  6. Inoue S, Watanabe R*, Ishitsuka Y, Nakamura Y, Fujisawa Y, Okiyama N, Fujimoto M. Successful Treatment of Acrodermatitis Continua of Hallopeau with an Anti-IL-17A Agent. Indian J Dermatol. 2021 Mar-Apr;66(2):225.
  7. Kawakami T*, Okiyama N, Kodera M, Seishima M, Yamaguchi Y. The relationship between anti-phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis. J Dermatol. 2021 Jun 25
  8. Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N*. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash. Rheumatology (Oxford). 2021 Jun 21
  9. Oya K, Ishitsuka Y*, Nakamura Y, Watanabe R, Okiyama N, Fujimoto M, Fujisawa Y. Papulonodular lesions in Erdheim–Chester disease. J Dermatol. 2021 Jun 2
  10. Nakamura Y*, Ishitsuka Y, Sasaki K, Ishizuki S, Tanaka R, Okiyama N, Furuta J, Fujimoto M, Yamada T, Fujisawa Y. A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split-thickness skin graft in large or muscle-exposing defects: The NPSG study. J Dermatol. 2021 May 24
  11. Miyauchi T, Suzuki S, Takeda M, Peh JT, Aiba M, Natsuga K, Fujita Y, Takeichi T, Sakamoto T, Akiyama M, Shimizu H, Nomura T*. Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism. Am J Hum Genet. 2021 May 12
  12. Tawara N, Yamashita S, Nagatoshi C, Nakajima M, Ichimura Y, Okiyama N, Ando Y. Anti-NXP2 antibody-positive dermatomyositis with aortic thrombus in normal aortic wall. Rheumatology (Oxford). 2021 May 14;60(5):e159-e161.
  13. Endo R, Nakamura Y*, Inoue S, Fujisawa Y. Cutaneous metastasis of renal pelvic urothelial carcinoma mimicking cutaneous angiosarcoma. Jpn J Clin Oncol. 2021 May 4
  14. Okiyama N. Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies. J Clin Med. 2021 Apr 16;10(8):1725. Review
  15. Maeda A, Nakamura Y*, Ishizuki S, Kubota N, Okiyama N, Endo R, Iwasaki R, Oya K, Fujisawa Y. Invasive Squamous Cell Carcinoma and Numerous Bowen Disease Lesions of the Hand and Foot With Infection of HPV-18 and HPV-45. Am J Dermatopathol. 2021 Apr 21
  16. Fukuzono M, Sasaki K, Ichimura Y, Inoue S, Iwasaki R, Imai H, Saito A, Kubota N, Tanaka R, Nakamura Y, Fujisawa Y, Fujimoto M, Nomura T, Okiyama N*. A case of anti-PL-7 antibody-positive antisynthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes. Rheumatology (Oxford). 2021 Apr 22
  17. Okiyama N*, Ichimura Y, Shobo M, Tanaka R, Kubota N, Saito A, Ishitsuka Y, Watanabe R, Fujisawa Y, Nakamura Y, Murakami A, Kayama H, Takeda K, Fujimoto M. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis. Ann Rheum Dis. 2021 Apr 2
  18. Komura K*, Ichimura Y, Okiyama N, Watanabe K, Muramoto H, Matsushita T. Augmented Interferon I signaling in a patient with COVID toes. J Dermatol. 2021 Mar 21.
  19. Kishi T*, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease – a case report. Pediatr Rheumatol Online J. 2021 Mar 19;19(1):34.
  20. Fujisawa Y*, Ito T, Kato H, Irie H, Kaji T, Maekawa T, Asai J, Yamamoto Y, Fujimura T, Nakai Y, Yasuda M, Matsuyama K, Muto I, Matsushita S, Uchi H, Nakamura Y, Uehara J, Yoshino K. Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases. Eur J Cancer. 2021 Mar
  21. Nakamura Y*, Nakayama M, Nishimura B, Okiyama N, Tanaka R, Ishitsuka Y, Matsumoto S, Fujisawa Y. Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy. Front Oncol. 2021 Feb 26
  22. Endo R, Nakamura Y*, Fujisawa Y. Glomus tumour of the back with a unique round-bottom flask-shaped lesion. Jpn J Clin Oncol. 2021 Feb 24
  23. Shiga M, Miyazaki J*, Tanuma K, Nagumo Y, Yoshino T, Kandori S, Negoro H, Kojima T, Tanaka R, Okiyama N, Fujisawa Y, Watanabe M, Yamasaki S, Kiyohara H, Watanabe M, Sato TA, Tahara H, Nishiyama H, Yano I. The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells. Cancer Immunol Immunother. 2021 Feb 11
  24. Nakamura Y*, Sasaki K, Ishizuki S, Inoue S, Okune M, Kubota N, Okiyama N, Furuta J, Fujisawa Y. Invasive and in situ lesions of squamous cell carcinoma are independent factors for postoperative surgical-site infection after outpatient skin tumors surgery: A retrospective study of 512 patients. J Dermatol. 2021 Feb 9.
  25. Ishizuki SNakamura Y*, Maruyama H,Okiyama N, Tanaka R, Oya K, Furuta J, Fujisawa Y. Pigmented Bowen’s disease on the proximal nail fold with extensive, parallel pigmented lines in dermoscopy. J Dermatol. 2021 Feb;48(2):e88-e89.
  26. Kurano MNakamura Y*, Kubota N,Okiyama N, Ishitsuka Y, Tanaka R, Furuta J, Watanabe R, Fujisawa Y. Mucinous metaplasia with glandular structures of the labia minora. J Dermatol. 2021 Feb;48(2):e118-e119.
  27. Koguchi-Yoshioka H, Watanabe R*, Matsumura Y,Okiyama N, Ishitsuka Y, Nakamura Y, Fujisawa Y, Fujimoto M. The possible linkage of granzyme B-producing skin T cells with the disease prognosis of alopecia areata. J Invest Dermatol. 2021 Feb;141(2):427-429.
  28. Koguchi-Yoshioka H, Hoffer E, Cheuk S, Matsumura Y, Vo S, Kjellman P, Grema L, Ishitsuka Y, Nakamura Y, Okiyama N, Fujisawa Y, Fujimoto M, Eidsmo L, Clark RA, Watanabe R*. Skin T cells maintain their diversity and functionality in the elderly. Commun Biol. 2021 Jan 4;4(1):13.
  29. Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, Suzuki S, Okiyama N, Fujimoto M, Nishino I*. Pathological features of anti-Mi-2 dermatomyositis. Neurology. 2021 Jan 19;96(3):e448-e459.
  30. Matsumura Y, Watanabe R*, Vo S, Koguchi-Yoshioka H, Furuta J, Inoue S, Ishitsuka Y, Nakamura Y,Okiyama N, Fujisawa Y, Fujimoto M. Interleukin-23 promotes CD103-negative Th17 in psoriatic non-lesional skin. J Dermatol Sci. 2021 Jan;101(1):72-74.

2020年


論文
  1. Nakamura Y*, Zhenjie Z, Oya K, Tanaka R, Ishitsuka Y, Okiyama N, Watanabe R, Fujisawa Y. Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma. Front Oncol. 2020 Dec 17;10:524700.
  2. Nomura T*, Takeda M, Teng Peh J, Orita A, Inamura E, Miyauchi T, Suzuki S, Moriuchi R, Shimizu H. Symmetrical acral keratoderma: A waxing and waning scaly pigmented skin lesions on the acral extremities. J Dermatol. 2020 Dec 19.
  3. Miyake Z, Ishii A*,Okiyama N, Tamaoka A. Amyopathic dermatomyositis combined with peripheral neuropathy. BMJ Case Rep. 2020 Nov 30;13(11):e237250.
  4. Murase C, Takeichi T,Nomura T, Ogi T, Akiyama M*. Hereditary mucoepithelial dysplasia/autosomal-dominant IFAP syndrome is a clinical spectrum due to SREBF1 variants. J Invest Dermatol. 2020 Nov 27
  5. Saito A, Ichimura Y, Kubota N, Tanaka R, Nakamura Y, Fujisawa Y, Watanabe R, Ishitsuka Y, Fujimoto M, Okiyama N*. Interferon-γ-stimulated apoptotic keratinocytes promote sclerodermatous changes in chronic graft-versus-host disease. J Invest Dermatol. 2020 Nov 23
  6. Kume M, Arase N*,Okiyama N, Koguchi-Yoshioka H, Tada T, Saruban H, Fujimoto M. Unilateral heliotrope rash: a warning sign for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2020 Nov 16:keaa574
  7. Shimizu T, Saito C*, Watanabe M, Ishii R, Kawamura T, Nagai K, Fujita A, Kaneko S, Kai H, Morito N, Usui J, Yokosawa M, Kondo Y, Inoue S,Okiyama N, Yamagata K. Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement. Intern Med. 2020 Nov 2.
  8. Kubota N, Saito A, Tanaka R, Nakamura Y, Watanabe R, Fujisawa Y, Ishitsuka Y, Clausen BE, Fujimoto M,Okiyama N*Langerhans cells suppress CD8+ T cells in situ during mucocutaneous acute graft-versus host disease. J Invest Dermatol. 2020 Oct 19
  9. Tanaka R, Ichimura Y, Kubota N, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Kanzaki M, Mizuno S, Takahashi S, Fujimoto M,Okiyama N*. Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6. Commun Biol. 2020 Oct 15;3(1):571.
  10. Ogawa T, Ishitsuka Y*, Nakamura Y, Okiyama N, Watanabe R, Fujisawa Y, Fujimoto M. Honey and Chamomile Activate Keratinocyte Antioxidative Responses via the KEAP1/NRF2 System. Clin Cosmet Investig Dermatol. 2020;13:657-660
  11. Yamamoto T*, Ito T, Asano Y, Sato S, Motegi SI, Ishikawa O, Matsushita T, Takehara K, Makino T, Okiyama N, Fujimoto M, Jinnin M, Ihn H. Characteristics of Japanese patients with eosinophilic fasciitis: a multicenter brief study. J Dermatol. 2020 Dec;47(12):1391-1394
  12. Kubota N, Inoue S, Saito A, Tanaka R, Nakamura Y, Ishitsuka Y, Furuta J, Fujisawa Y, Okiyama N*. Widespread involvement of purpura related to gastrointestibnal involvements in adults with immunoglogulin A vasculitis. J Cutan Immunol Allergy. 2020 Oct;3(4):104-108
  13. Yamashita K, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Okiyama N, Nagaoka S, Shimada K, Sugii S, Katayama M, Hirohata S, Okamoto A, Chiba N, Suematsu E, Setoguchi K, Migita K, Sumida T, Tohma S, Hamaguchi Y, Hasegawa M, Sato S, Kawaguchi Y, Takehara K, Tsuchiya N*. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis. Rheumatology (Oxford). 2020 Nov 1;59(11):3553-3562
  14. Teramura T,Nomura T*. Acute skin barrier disruption alters the secretion of lamellar bodies via the multilayered expression of ABCA12. J Dermatol Sci. 2020 Dec; 100:50-57
  15. Ogawa T, Ishitsuka Y*, Nakamura Y, Kubota N, Saito A, Fujisawa Y, Watanabe R,Okiyama N, Suga Y, Roop DR, Fujimoto M. NRF2 Augments Epidermal Antioxidant Defenses and Promotes Atopy. J Immunol. 2020 Aug 15;205(4):907-914.
  16. Matsushita S*,Nakamura Y, Tanaka R, Araki R, Yamamura K, Yoshioka M, Inoue A, Komori T, Saito S, Teramoto Y,Nakamura Y, Fujisawa Y, Aoki M. Prediction of the invasive level of basal cell carcinomas in the facial area: Analysis of 718 Japanese cases. J Dermatol Sci. 2020 Sep;99(3):152-157.
  17. Nakagawa Y, Odomari K, Imanaka Y, Katayama I, Ichimura Y, Okiyama N, Fujimoto M*. A case of anti‐NXP‐2‐positive dermatomyositis with generalized subcutaneous edema. J Cutan Immunol Allergy. 2020 Jul 12.
  18. Fujita Y*, Komatsu M, Lee SE, Kushida Y, Nakayama-Nishimura C, Matsumura W, Takashima S, Shinkuma S,Nomura T, Masutomi N, Kawamura M, Dezawa M, Shimizu H. Intravenous Injection of Muse Cells as a Potential Therapeutic Approach for Epidermolysis Bullosa. J Invest Dermatol. 2020 Dec;141:198-202
  19. Nakamura Y*, Ishitsuka Y, Tanaka R,Okiyama N, Watanabe R, Saito A, Furuta J, Fujisawa Y. Frequent brain metastases during treatment with BRAF/MEK inhibitors: A retrospective single institutional study. J Dermatol. 2020 Oct;47(10):1191-1194.
  20. Konishi R, Ishitsuka Y*, Inoue S, Saito A, Nakamura Y, Watanabe R,Okiyama N, Chiba S, Nishikii H, Fujimoto M, Fujisawa Y. Aggressive conjunctival carcinoma arising on poorly controlled sun-damaged graft-versus-host disease. Eur J Dermatol. 2020 Jun 1;30(3):313-314.
  21. Endo R, Nakamura Y*, Ishizuki S, Ishitsuka Y, Watanabe R, Okiyama N, Ito Y, Nagafuchi M, Mizokami Y, Fujisawa Y. Ulcerative esophagitis associated with combined nivolumab and ipilimumab therapy. J Dermatol. 2020 Aug;47(8):e299-e300.
  22. Nakamura Y*, Inoue S, Maruyama H, Matsumura Y, Tanaka R, Ishitsuka Y, Watanabe R, Okiyama N, Fujisawa Y. Verrucous melanoma of the ankle with pseudoepitheliomatous hyperplasia on the skin graft. J Dermatol. 2020 Aug;47(8):e300-e302.
  23. Okiyama N*, Nakamura Y, Ishitsuka Y, Inoue S, Kubota N, Saito A, Watanabe R, Fujisawa Y, Igawa K. Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e474-e476.
  24. Fujisawa Y*, Fujimura T, Matsushita S, Yamamoto Y, Uchi H, Otsuka A, Funakoshi T, Miyagi T, Hata H, Gosho M, Kambayashi Y, Aoki M, Yanagi T, Ohira A, Nakamura Y, Maeda T, Yoshino K. The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multi-center, prospective, observational study. Br J Dermatol. 2020 Nov;183(5):831-839
  25. Inoue M, Tanboon J, Hirakawa S, Komaki H, Fukushima T, Awano H, Tajima T, Yamazaki K, Hayashi R, Mori T, Shibuya K, Yamanoi T, Yoshimura H, Ogawa T, Katayama A, Sugai F, Nakayama Y, Yamaguchi S, Hayashi S, Noguchi S, Tachimori H, Okiyama N, Fujimoto M, Nishino I*. Association of Dermatomyositis Sine Dermatitis and With Anti-Nuclear Matrix Protein 2 Autoantibodies. JAMA Neurol. 2020 Apr; 77(7):1-6
  26. Matsuya T, Nakamura Y*, Matsushita S, Tanaka R, Teramoto Y, Asami Y, Uehara J, Aoki M, Yamamura K, Nakamura Y, Fujisawa Y, Livingstone E, Zimmer L, Schadendorf D, Kagamu H, Fujimoto M, Honma M, Ishida-Yamamoto A, Araki R, Yamamoto A. Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study. J Dermatol. 2020 Jun;47(6):629-635.
  27. Yu Y, Furuta J*, Watanabe R, Inoue S, Nakamura Y, Ishitsuka Y, Okiyama N, Ishii Y, Fujisawa Y. Case of bullous pemphigoid who achieved a long-term remission by a single course of high-dose i.v. immunoglobulin monotherapy. J Dermatol. 2020 Jun;47(6):e225-e227.
  28. Oya K, Inoue S, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Taguchi S, Fujimoto M, Okiyama N*. Pregnancy triggers the onset of anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: a case series. Rheumatology (Oxford). 2020 Jun 1;59(6):1450-1451
  29. Nakamura Y*, Inoue S, Okiyama N, Fujisawa Y. Inverted nipple-like nevus lipomatosus cutaneous superficialis. Jpn J Clin Oncol. 2020 Jun 10;50(6):722-723.
  30. Nakamura Y*, Ishizuki S, Iwasaki R, Ishitsuka Y, Watanabe R, Saito A, Furuta J, Okiyama N, Fujisawa Y. Double primary malignant melanoma on the forearm and the chest with detection of common axillary sentinel lymph nodes. J Dermatol. 2020 May;47(5):e187-e188.
  31. Ishizuki S, Nakamura Y*Okiyama N, Watanabe R, Ishitsuka Y, Fujisawa Y. Squamous cell carcinoma of the nose presenting with a giant cutaneous horn: A unique clinical presentation. J Dermatol. May;47(5):e185-e186.
  32. Ikeda T*, Kawakami T, Arimura Y, Ishiguro N, Ishizu A, Ito F, Ito-Ihara T, Okiyama N, Ono S, Suzuki K, Sugawara K, Seishima M, Kodera M, Tanaka M, Hasegawa M, Furukawa F, Yamaguchi Y, Yoshizaki A; Revised Committee for guidelines for the management of vasculitis, vascular disorders of the Japanese Dermatological Association. Survey of Japanese dermatological vasculitis specialists on cases of cutaneous arteritis (cutaneous polyarteritis nodosa). J Dermatol. 2020 May;47(5):534-537.
  33. Anju K, Nakamura Y*Okiyama N, Ishitsuka Y, Saito A, Watanabe R, Fujisawa Y. Angiomatoid Spitz nevus with surrounding pagetoid melanocytic proliferation on the sole of the foot: An unusual case report with immunohistochemical studies for angiogenic factors. J Dermatol. 2020 May;47(5):538-541.
  34. Nakamura Y*, Ishizuki S, Ishitsuka Y, Watanabe R, Saito A, Furuta J, Okiyama N, Fujisawa Y. Multiple, lipid-containing, subcutaneous cysts suspected of end-stage nodular cystic fat necrosis. J Dermatol.  2020 Mar;47(3):e85-e87.
  35. Ogawa T, Ishitsuka Y*, Inoue S, Nakamura Y, Saito A, Okiyama N, Fujisawa Y, Furuta JI, Watanabe R, Fujimoto M. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates epidermal keratinization under psoriatic skin inflammation. Am J Pathol. 2020 Mar;190(3):577-585.
  36. Saito A*Okiyama N, Inoue S, Kubota N, Nakamura Y, Ishitsuka Y, Watanabe R, Nakano H, Fujisawa Y. Novel mutation of the ferrochelatase gene in a Japanese family with erythropoietic protoporphyria. J Dermatol. 2020 Apr; 47(4):e114-e116
  37. Nakamura Y*, Ishizuki S, Iwasaki R, Okiyama N, Ishitsuka Y, Matsumura Y, Tanaka R, Maruyama H, Watanabe R, Fujisawa Y. Remarkable elevation of fibrinolysis markers and procalcitonin associated with dabrafenib plus trametinib combination therapy: Uncommon adverse events. J Dermatol. 2020 Feb;47(2):e43-e44
  38. Maeda T*, Yoshino K, Nagai K, Oaku S, Kato M, Hiura A, Uehara J, Fujisawa Y. Effect of the lymphovascular plugging metastasis pattern in extramammary Paget disease on identifying metastatic lesions by imaging tests: An autopsy case series. Br J Dermatol. 2020 Feb;182(2):493-495.
  39. *Corresponding Author

著書・総説
  1. 沖山奈緒子「[特集 新組織学シリーズI:最新の皮膚科学]筋炎特異的自己抗体による皮膚筋炎のサブグループ」生命の科学(公益財団法人金原一郎記念医学医療振興財団/医学書院)Vol.71 No.6, 2020年12月15日
  2. 沖山奈緒子「新・皮膚科セナトリウム エリテマトーデス・皮膚筋炎 1.筋炎特異抗体別サブグループ分類による皮膚筋炎の診断・治療方針のパラダイムシフト」日本皮膚科学会雑誌 Vol.130, No.12, 2020年11月15日
  3. 沖山奈緒子、保田晋助「免疫・炎症疾患のすべて III 免疫・炎症疾患における病歴・身体所見 皮膚、粘膜」日本医師会雑誌 第149巻・特別号(2)、2020年10月15日
  4. 沖山奈緒子「◆特集/”中毒疹”診断のロジックと治療 膠原病にみられる皮疹 -鑑別のポイントー」Monthly Book Derma. No. 296、2020年5月15日
  5. 沖山奈緒子「皮膚筋炎の脂漏部位紅斑」皮膚病診療 第42巻・第4号、2020年4月1日

2019年


論文
  1. Oya K, Nakamura Y*, Ishitsuka Y, Okiyama N, Watanabe R, Fujisawa Y. Two cases of multiple pilosebaceous cysts with hybrid cysts. Eur J Dermatol. 2019 Dec 1;29(6):653-654.
  2. Widya Monica P, Ishitsuka Y*, Kawakita H, Inoue S, Nakamura Y, Watanabe R, Okiyama N, Fujimoto M, Fujisawa Y. Nail apparatus squamous cell carcinoma mimicking paronychia. J Dermatol. 2019 Dec;46(12):e460-e461
  3. Niijima YIshitsuka Y*, Inoue S, Maruyama H, Nakamura Y, Fujisawa Y, Fujimoto M. Reconstruction Using a Vertical “Sagging Cheek” Advancement Flap for Defects Following Full-Thickness Excision of Non-Melanoma Skin Cancer in the Elderly: A Case Series. Eur J Dermatol. 2019 Dec 1;29(6):654-656.
  4. Nakamura Y*, Ishitsuka Y,  Tanaka R, Okiyama N, Saito A, Watanabe R, Fujisawa Y. Acral lentiginous melanoma and mucosal melanoma expressed less programmed-death 1 ligand than cutaneous melanoma: a retrospective study of 73 Japanese melanoma patients. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e424-e426
  5. Okiyama N*, Fujimoto M. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies. F1000Res. 2019 Nov 21;8. Review
  6. Ogawa T,Ishitsuka Y*, Saito A, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M. Immune microenvironment controls the outcome of PD-1 blockade in cutaneous immune response. Allergy. 2019 Nov;74(11):2257-2261
  7. Ishitsuka Y*, Inoue S, Furuta JI, Koguchi-Yoshioka H, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Enokizono T, Hiroko F, Suzuki H, Nishino I, Kosaki K, Fujimoto M. Sweat Retention Anhidrosis Associated with Tubular Aggregate Myopathy. Br J Dermatol. 2019 Nov;181(5):1104-1106. 
  8. Saito A, Nakamura Y*, Tanaka R, Inoue S, Okiyama N, Ishitsuka Y, Maruyama H, Watanabe R, Yoshida K, Ishiko A, Fujimoto M, Shinkuma S, Fujisawa Y. Unusual Bone Lesions with Osteonecrosis Mimicking Bone Metastasis of Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa. Acta Derm Venereol. 2019 Nov 1;99(12):1166-1169
  9. Kato M, Yoshino K, Maeda T*, Nagai K, Oaku S, Hiura A, Fujisawa Y. Single-agent taxane is useful in palliative chemotherapy for advanced extramammary Paget’s disease; A Case Series. Br J Dermatol. 2019 Oct;181(4):831-832.
  10. Nakamura N*, Izumi R, Hoshi Y, Takai Y, Ono R, Suzuki N, Nagai T, Ishii Y, Ishii T, Harigae H, Okada S, Aiba S, Okiyama N, Fujimoto M, Kuroda H, Tateyama M, Aoki M. FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis. Rheumatology (Oxford). 2019 Oct; 58(10):1888.
  11. Nakamura Y*Okiyama N, Ishitsuka Y, Watanabe R, Saito A, Fujimoto M, Okamura K, Suzuki T, Fujisawa Y. A toddler case of keratosis follicularis squamosa (Dohi) successfully treated with salicylic acid ointment. Eur J Dermatol. 2019 Oct 1;29(5):544-546.
  12. Iga N, Otsuka A*, Hirata M, Kataoka TR, Irie H, Nakashima C, Matsushita S, Uchi H, Yamamoto Y, Funakoshi T, Fujisawa Y, Yoshino K, Fujimura T, Hata H, Ishida Y, Kabashima K. Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy. Cancer Sci. 2019 Nov;110(11):3434-3441.
  13. Okiyama N*, Yamaguchi Y, Kodera M, Hamaguchi Y, Yokozeki H, Ishiguro N, Fujimoto M. Distinct Histopathologic Patterns of Finger Eruptions in Dermatomyositis Based on Myositis-Specific Autoantibody Profiles. JAMA Dermatol. 2019 Sep;155(9):1080-1082.
  14. Fujimura T*, Fujisawa Y, Kambayashi Y, Aiba S. Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside. Cancers (Basel). 2019 Sep;11(9). Review
  15. Hiruta A, Yoshino K, Maeda T, Nagai K, Oaku S, Yamashita C, Kato M, Uehara J, Fujisawa Y. Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases. Front Med (Lausanne). 2019 Sep 18;6:207
  16. Kubota N, Furuta JI, Onizawa S, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa YOkiyama N*Fujimoto M. Oral pilocarpine alleviates the symptoms of acquired idiopathic generalised anhidrosis. Eur J Dermatol. 2019 Aug; 29(4):422-423.
  17. Fujisawa Y*, Inoue S, Nakamura Y. The Possibility of Deep Learning-Based, Computer-Aided Skin Tumor Classifiers. Front Med (Lausanne). 2019 Aug 27;6:191. Review
  18. Inoue M, Tanboon J, Okubo M, Theerawat K, Saito Y, Ogasawara M, Indrawati LA, Uruha A, Okiyama N, Fujimoto M, Suzuki S, Nishino I*. Absence of sarcoplasmic MxA expression in antisynthetase syndrome in cohort of 194 cases. Neuropathol Appl Neurobiol. 2019 Aug;45(5):523-524.
  19. Vo S, Watanabe R*, Koguchi-Yoshioka H, Matsumura Y, Ishitsuka Y, Nakamura Y, Okiyama N, Fujisawa Y, Fujimoto M. CD8 resident memory T cells with IL-17A-producing potential are accumulated in disease-naïve non-lesional sites of psoriasis possibly in correlation with disease duration. Br J Dermatol. 2019 Aug;181(2):410-412.
  20. Sato Y, Fujimura T*, Tanita K, Chunbing L, Matsushita S, Fujisawa Y, Otsuka A, Yamamoto Y, Hidaka T, Aiba S.Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget’s disease. Exp Dermatol. 2019 Aug;28(8):933-939.
  21. Maeda T*, Yoshino K, Yamashita C, Nagai K, Oaku S, Kato M, Hiura A, Uehara J, Fujisawa Y. Dynamics of neutrophil and C-reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib. J Dermatol. 2019 Aug;46(8):716-719.
  22. Takamuki ROkiyama N*, Inoue S, Endo R, Kondo Y, Chino Y, Sumida T, Fujimoto M. Successful treatment of refractory cutaneous lupus vasculitis with i.v. immunoglobulin. J Dermatol. 2019 Jul;46(7):e253-e255.
  23. Watanabe R*. Protective and pathogenic roles of resident memory T cells in human skin disorders. J Dermatol Sci. 2019 Jul;95(1):2-7. Review
  24. Ishizuki S, Nakamura Y*Okiyama N, Saito A, Ishitsuka Y, Watanabe R, Fujimoto M, Fujisawa Y. Microcystic adnexal carcinoma with large cysts: unusual clinical presentation and histological findings. Eur J Dermatol. 2019 Jun;29(3):337-339.
  25. Yamazaki N*, Kiyohara Y, Uhara H, Uehara J, Fujisawa Y, Takenouchi T, Otsuka M, Uchi H, Ihn H, Hatsumichi M, Minami H. Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma. Cancer Sci. 2019 Jun;110(6):1995-2003.
  26. Hiura A, Yoshino K, Maeda T*, Nagai K, Oaku S, Kato M, Fujisawa Y. Chemoradiotherapy could improve overall survival of patients with stage IV cutaneous squamous cell carcinoma: analysis of 34 cases. Br J Dermatol. 2019 Jun;180(6):1557-1558.
  27. Nakamura Y*, Sasaki K, Fujisawa Y, Okiyama N, Ishitsuka Y, Oya K, Watanabe R,Fujimoto M. Pencil-core granuloma with extensive calcinosis: An unusual case report. J Dermatol. 2019 Jun;46(6):e193-e195.
  28. Nakamura Y*. Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events. Front Med (Lausanne). 2019 May 29;6:119. Review
  29. Nakamura Y*, Tanaka R, Maruyama H, Ishitsuka Y, Okiyama N, Watanabe R, Fujimoto M, Fujisawa Y. Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies. Jpn J Clin Oncol. 2019 May 1;49(5):431-437. 
  30. Nakamura Y*, Watanabe R, Zhenjie Z, Koguchi-Yoshioka H, Vo S, Oya K, Matsumura Y, Tanaka R, Okiyama N, Ishitsuka Y, Fujimoto M, Fujisawa Y. CD103 negative memory T cells may play important roles in making regulatory T-cell-enriched environments in skin tumours. J Eur Acad Dermatol Venereol.  2019 May;33(5):e211-e214.
  31. Okiyama N*, Inoue S, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Fujimoto M. Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis. Br J Dermatol. 2019 May;180(5):1226-1227.
  32. Nakamura Y*, Fujisawa Y, Ishizuki S, Okiyama N, Ishitsuka Y, Watanabe R, Fujimoto M. Linearly distributed multiple lipomas: An unusual case report. J Dermatol. 2019 May;46(5):e175-e176.
  33. Fujisawa Y*, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murata N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system. J Dermatol Sci. 2019 May;94(2):284-289.
  34. Fujisawa Y*, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murao N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N.  Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma. Cancer Med. 2019 May;8(5):2146-2156.
  35. Ogawa TOkiyama N*, Takamuki R, Inoue S, Saito A, Nakamura Y, Ishitsuka Y, Watanabe R, Fujisawa Y, Fujimoto M. Juvenile case of multiple morphea profunda resulting in joint contracture that was successfully treated with cyclosporin A: A case report and review of the published works. J Dermatol. 2019 Apr;46(4):354-357.
  36. Oya KWatanabe R*, Konishi R, Inoue S, Nakamura Y, Ishitsuka Y, Maruyama H, Okiyama N, Fujisawa Y, Fujimoto M. Possible involvement of IgE antibody in epidermolysis bullosa acquisita: detection and correlation. Eur J Dermatol. 2019 Apr 1;29(2):210-212.
  37. Ueda-Hayakawa I*, Hamaguchi Y, Okiyama N, Motegi SI, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M. Autoantibody to transcriptional intermediary factor-1β as myositis-specific antibody: clinical correlation with CADM or DM with mild myopathy. Br J Dermatol. 2019 Apr;180(4):881-887.
  38. Fujimura T*, Sato Y, Tanita K, Lyu C, Kambayashi Y, Amagai R, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Uchi H, Yamamoto Y, Hata H, Funakoshi T, Nonomura Y, Tanaka R, Okuhira H, Wada N, Hashimoto A, Aiba S. Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma. Front Med (Lausanne). 2019 Apr 26;6:86.
  39. Nakamura Y*, Maruyama H, Fujisawa Y, Inoue S, Okiyama N, Ishitsuka Y, Watanabe R, Fujimoto M. Subungual exostosis with postoperative recurrence followed by spontaneous regression. J Dermatol. 2019 Mar;46(3):e86-e87.
  40. Shibao K, Watanabe R*, Saito A, Ishii Y, Nakamura Y, Ishitsuka Y, Okiyama N, Fujisawa Y, Fujimoto M. Lichen myxedematosus associated with monoclonal gammopathy of undetermined significance: A case report and a review of Japanese patients. J Dermatol. 2019 Jan;46(1):e32-e33.
  41. Fujisawa Y*, Otomo Y, Ogata Y, Nakamura Y, Fujita R, Ishitsuka Y, Watanabe R, Okiyama N, Ohara K, Fujimoto M. Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis. Br J Dermatol. 2019 Feb;180(2):373-381.
  42. Koguchi-Yoshioka H, Watanabe R*, Fujisawa Y, Ishitsuka Y, Nakamura Y,  Okiyama N, Fujimoto M. Skin resident memory T cell population is not effectively constructed in systemic sclerosis. Br J Dermatol. 2019 Jan;180(1):219-220.
  43. Tanaka R, Yonemori K*, Hirakawa A, Kinoshita F, Kobayashi Y, Yamazaki N, Fujimoto M, Tamura K, Fujiwara Y. Anticancer Agent-Induced Life-Threatening Skin Toxicities: A Database Study of SpontaneousReporting Data. Oncologist.2019 Feb;24(2):266-272.
  44. Iga N, Otsuka A*, Yamamoto Y, Nakashima C, Honda T, Kitoh A, Nakajima S, Egawa G, Nomura T, Dainichi T, Matsushita S, Tanizaki H, Yamamoto Y, Funakoshi T, Fujisawa Y, Fujimura T, Hata H, Ishida Y, Kabashima K, Accumulation of exhausted CD8+ T cells in extramammary Paget’s disease. PLoS One. 2019 Jan 25;14(1):e0211135.
  45. *Corresponding author

著書・総説
  1. 沖山奈緒子「特集 知っておくべき・知っておきたい小児の皮膚疾患/症状 VI. 全身疾患・薬による皮膚疾患/症状 皮膚筋炎・限局性強皮症」小児科診療 第82巻・11号、2019年11月
  2. 沖山奈緒子「II専門医の管理・治療が必要な疾患のガイドライン 全身性疾患/膠原病19全身性強皮症」ガイドライン外来診療2019(第19版)、日経メディカル開発、2019年3月4日
  3. 沖山奈緒子「特集I 炎症性筋疾患における筋炎特異的自己抗体 皮膚筋炎における筋炎特異的自己抗体」脳神経内科 Vol.91 No.2、2019年8月
  4. 井上 紗惠、藤本 学「【皮膚科で使うMTXの完全マニュアル】Part4:乾癬以外の皮膚疾患へのMTXの応用総説(5):関節リウマチ以外の膠原病、血管炎」、Visual Dermatology 18巻1号、2019年1月

2018年


論文
  1. Fujisawa Y*, Funakoshi T, Nakamura Y, Ishii M, Asai J, Shimauchi T, Fujii K, Fujimoto M, Katoh N, Ihn H. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan. J Dermatol Sci. 2018 Dec;92(3):230-236.
  2. Ishitsuka Y*, Iwamoto K, Oya K, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M. Pegylated interferon-α2b for local control of Langerhans cell sarcoma. Eur J Dermatol. 2018 Dec 1;28(6):835-836.
  3. Nakamura Y*, Ishitsuka Y, Fujisawa Y, Konishi R, Maruyama H, Inoue S, Okiyama N, Watanabe R, Fujimoto M. Pelvic reactive lymphadenopathy mimicking lymph node metastasis of heel malignant melanoma. Eur J Dermatol. 2018 Dec 1;28(6):841-843.
  4. Fujimura T*, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S. Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma. Front Oncol. 2018 Nov 19;8:530.
  5. Nakamura Y*, Fujisawa Y, Tanaka R, Maruyama H, Ishitsuka Y, Okiyama N, Watanabe R, Fujimoto M. Use of immune checkpoint inhibitors prolonged overall survival in a Japanese population of advanced malignant melanoma patients: Retrospective single institutional study. J Dermatol. 2018 Nov;45(11):1337-1339. 
  6. Inoue SOkiyama N*, Shobo M, Motegi SI, Hirano H, Nakagawa Y, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Fujimoto M. Diffuse erythema with ‘angel wings’ sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis. Br J Dermatol. 2018 Dec;179(6):1414-1415.
  7. Ishida Y, Nakashima C, Kojima H, Tanaka H, Fujimura T, Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Otsuka A*, Kabashima K*. Killer immunoglobulin-like receptor genotype did not correlate with response to anti-PD-1 antibody treatment in a Japanese cohort. Sci Rep. 2018 Oct 29;8(1):15962.
  8. Nakamura Y*, Fujisawa Y, Ishitsuka Y, Tanaka R, Maruyama H, Okiyama N, Watanabe R, Fujimoto M. Negative-pressure closure was superior to tie-over technique for stabilization of split-thickness skin graft in large or muscle-exposing defects: A retrospective study. J Dermatol. 2018 Oct; 45(10):1207-1210.
  9. Shibao K, Watanabe R*, Saito A, Ishii Y, Nakamura Y, Ishitsuka Y, Okiyama N, Fujisawa Y, Fujimoto M. Lichen myxedematosus associated with monoclonal gammopathy of undetermined significance: A case report and a review of Japanese patients. J Dermatol. 2018 Jul 2.
  10. Fujisawa Y*, Otomo Y, Ogata Y, Nakamura Y, Fujita R, Ishitsuka Y, Watanabe R, Okiyama N, Ohara K, Fujimoto M. Deep learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumor diagnosis. Br J Dermatol. 2018 Jun 28.
  11. Nakamura Y*, Iwamoto K, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Kondo Y, Sakashita S, Fujimoto M. Multiple haemangiomas in TAFRO syndrome with atypical features of glomeruloid and epithelioid haemangiomas. Eur J Dermatol. 2018 Jun 1;28(3):371-372.
  12. Iwamoto K, Nakamura Y*, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Fujimoto M. Depigmented extramammary Paget’s disease without histological dermal invasion identified by multiple inguinal and pelvic lymph node metastases. Eur J Dermatol. 2018 Jun 1;28(3):387-388.
  13. Saito A, Fujisawa Y*, Maruyama H, Nakamura Y, Ishitsuka Y, Watanabe R, Okiyama N, Fujimoto M. Subungual melanoma complicated by hydroxyurea-induced melanonychia with non-melanoma Hutchinson’s sign. Eur J Dermatol. 2018 Aug 1;28(4):559-561.
  14. Saito AOkiyama N*, Tanaka R, Maruyama H, Fujimoto M. A Case of Refractory Subcutaneous Panniculitis-like T-cell Lymphoma with Bone Marrow and Lung Involvement Treated Successfully with Oral Etoposide. Acta Derm Venereol. 2018 Jun 8;98(6):610-611.
  15. Mimura T*, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T. Evidence-based clinical practice guideline for adult Still’s disease. Mod Rheumatol. 2018 Apr 13:1-53.
  16. Saito AOkiyama N*, Hitomi S, Anzawa K, Mochizuki T, Fujimoto M. Successful treatment of cutaneous phaeohyphomycosis caused by Exophiala lecanii-corni with voriconazole. J Dermatol. 2018 Oct;45(10):e271-e272.
  17. Saito AOkiyama N*, Kubota N, Nakamura Y, Fujisawa Y, Watanabe R, Ishitsuka Y, Bleackley RC, Fujimoto M. Blockade of granzyme B remarkably improves mucocutaneous diseases with keratinocyte death in interface dermatitis. J Invest Dermatol. 2018 Sep;138(9):2079-2083.
  18. Nakamura Y*, Takamuki R, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Fujimoto M. Congenital peristernal dermal sinus: A case report and published work review. J Dermatol. 2018 Sep;45(9):e242-e243.
  19. Oya K, Nakamura Y*, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Fujimoto M. Tufted angioma of the finger: A case of an uncommon location with unique dermoscopic features. J Dermatol. 2018 Aug;45(8):e236-e237.
  20. Hasegawa M*, Ishikawa O, Asano Y, Sato S, Jinnin M, Takehara K, Fujimoto M, Yamamoto T, Ihn H; Executive Committee of Guideline. Diagnostic criteria, severity classification and guideline of lichen sclerosus et atrophicus. J Dermatol. 2018 Aug;45(8):891-897.
  21. Matsuda T, Ueda-Hayakawa I*, Kambe N, Son Y, Ozaki Y, Hamaguchi Y, Takehara K,Fujimoto M, Okamoto H. Four cases of anti-Mi-2 antibody-positive dermatomyositis: relationship between anti-Mi-2 antibody titre and disease severity and activity. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e233-e234.
  22. Saito A, Okiyama N*, Iwamoto K, Inoue S, Koguchi-Yoshioka H, Fujimoto M. A case with anaphylactic shock induced by heparin lock flish injection. J Dermatol. 2018 Jul;45(7):e195-e196.
  23. Ogawa T, Ishitsuka Y*, Iwamoto K, Koguchi-Yoshioka H, Tanaka R, Watanabe R, Fujisawa Y, Fujimoto M. Programmed cell death 1 blockade-induced cutaneous sarcoid-like epithelioid granulomas in advanced melanoma: A case report. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e260-e261.
  24. Nakamura Y*, Saito A, Takamuki R, Inoue S, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Fujimoto M. Trichostasis spinulosa arising in isolated collagenoma of the scalp. Eur J Dermatol. 2018 Jul 5. 
  25. Ogawa TIshitsuka Y*, Inoue S, Fujisawa Y, Fujimoto M. Neurofibromatosis type 1-associated serious haemorrhagic events successfully treated with steroid pulse therapy. Eur J Dermatol. 2018 Jun 1;28(3):382-384.
  26. Ogawa TIshitsuka Y*, Fujisawa Y, Maruyama H, Nakamura Y, Tanaka R, Taguchi S, Fujimoto M. Bilateral metachronous cutaneous apocrine carcinoma with reduced PTEN expression. Eur J Dermatol. 2018 Jun 1;28(3):372-374.
  27. Iwamoto K, Fujisawa Y*, Ishitsuka Y, Maruyama H, Nakamura Y, Okiyama N, Watanabe R, Fujimoto M. A case of cutaneous angiosarcoma successfully treated with eribulin. Eur J Dermatol. 2018 Jun 1;28(3):410-412.
  28. Oya K, Watanabe R*, Inoue S, Obara N, Kiyoki Y, Sakata-Yanagimoto M, Chiba S, Saito C, Matsumura Y, Nakamura Y, Ishitsuka Y, Maruyama H, Okiyama N, Fujisawa Y, Fujimoto M. Bullous pemphigoid accompanied by IgA nephropathy and atypical haemolytic uraemic syndrome. Eur J Dermatol. 2018  Jun 1;28(3):421-422.
  29. Jinnin M*, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K, Hasegawa M, Fujimoto M, Ihn H. Guideline for diagnostic criteria, severity classification and treatment of eosinophilic fasciitis. J Dermatol. 2018 Jun;32(6):e233-e234.
  30. Okiyama N*, Asano Y, Hamaguchi Y, Jinnin M, Motegi S, Koizumi H, Hasegawa M, Ishikawa O, Sato S, Takehara K, Yamamoto T, Fujimoto M, Ihn H. Impact of a new simplified disability scoring system for adult patients with localized scleroderma. J Dermatol. 2018 Apr;45(4):431-435.
  31. Fujisawa Y*, Yoshino K, Fujimura T, Nakamura Y, Okiyama N, Ishitsuka Y, Watanabe R, Fujimoto M. Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor. Front Oncol. 2018 Mar 2;8:46.
  32. Nakamura Y*, Fujisawa Y, Okiyama N, Watanabe R, Tanaka R, Ishitsuka Y, Tahara H, Fujimoto M. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. J Dermatol Sci. 2018 Apr;90(1):46-51.
  33. Kochi Y*, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis. 2018 Apr;77(4):602-611.
  34. Nakamura Y*, Sasaki K, Fujisawa Y, Okiyama N, Watanabe R, Ishitsuka Y, Maruyama H, Ishii Y, Fujimoto M. Unusual association between digital mucous cyst and acquired ungual fibrokeratoma: A case report. J Dermatol. 2018 Feb 27.
  35. Oya K, Nakamura Y*, Fujisawa Y, Endo R, Tanaka R, Ishitsuka Y, Maruyama H, Watanabe R, Okiyama N, Fujimoto M. Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure. Eur J Dermatol. 2018 Feb 1;28(1):129-130.

著書・総説
  1. 沖山奈緒子「第14章 特殊な強皮症」、渡邊 玲「第18章 福祉その他」、強皮症を正しく理解するための本(編者 佐藤伸一、藤本 学、浅野善英、神人正寿)、医薬ジャーナル社、2018年11月30日
  2. 藤本 学「第1章 臨床力アップ!のための基礎知識 1.免疫臓器としての皮膚 C.抗体のはたらきと皮膚での免疫制御」「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 19.抗体医薬のまとめ」、藤澤康弘「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 6.メラノーマと免疫 C.免疫チェックポイント阻害薬の副作用」、沖山奈緒子「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 V. 膠原病 A. 膠原病での皮膚病変のメカニズム、C. 自己抗体による皮膚筋炎の分類」「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 XIV. GVHD」、渡邊 玲「第1章 臨床力アップ!のための基礎知識 2.T細胞 C. Resident memory T細胞」、石塚洋典「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 7.免疫から見た腫瘍 B. 日光角化症とTLR7アゴニスト」、中村貴之「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 7.免疫から見た腫瘍 C. Merkel細胞がんと免疫療法」、吉岡華子「第2章 臨床力アップ!!のための皮膚免疫アレルギーのコア知識 8.自己免疫性水疱症 B. 類天疱瘡・その他の水疱症」、臨床力がアップする! 皮膚免疫アレルギーハンドブック(編者 戸倉新樹、藤本 学、椛島健治)、南江堂、2018年11月
  3. 藤本 学「【膠原病・血管炎】2膠原病のかゆみ」、藤澤康弘「【腫瘍】8タキサン無効の血管肉腫に対する新規治療薬とは」、沖山奈緒子「【膠原病・血管炎】3筋炎特異抗体で皮膚筋炎の予後を予言する」What’s New in 皮膚科学2018-2019、メディカルレビュー社、2018年4月16日
  4. 沖山奈緒子「II専門医の管理・治療が必要な疾患のガイドライン 全身性疾患19全身性強皮症」ガイドライン外来診療2018(第18版)、日経メディカル開発、2018年3月12日
  5. 石井良征「27アナフィラクトイド紫斑」、沖山奈緒子「37皮膚筋炎」、井上紗惠「36尋常性痤瘡」ナースができる!皮膚病変の見極め術(トリアージ)40、南山堂、2018年3月12日

2017年


論文
  1. Fujisawa Y*, Yoshino K, Otsuka A,Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Gosho M, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S. Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab. J Dermatol Sci. 2017 Nov;88(2):225-231.
  2. Inoue S, Furuta JI, Fujisawa Y*, Onizawa S, Ito S, Sakiyama M, Kobayashi K, Kanou T, Iijima S, Ohi T, Okubo C, Moriyama Y, Okiyama N, Fujimoto M. Pyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study. J Dermatol. 2017 Nov;44(11):1281-1284.
  3. Ogawa T, Maruyama H*, Tanaka R, Fujisawa Y, Fujimoto M. Clear cell sarcoma of the scalp: A case report. J Dermatol. 2017 Nov;44(11):e276-e277.
  4. Ogawa TIshitsuka Y*, Koguchi-Yoshioka H, Tanaka R, Fujisawa Y, Ishii A, Tamaoka A, Fujimoto M. Polymyositis induced by PD-1 blockade in a patient in hepatitis B remission. J Neurol Sci. 2017 Oct 15;381:22-24.
  5. Oka A*, Asano Y, Hasegawa M, Fujimoto M, Ishikawa O, Kuwana M, Kawaguchi Y, Yamamoto T, Takahashi H, Goto D, Endo H, Jinnin M, Mano S, Hosomichi K, Mabuchi T, Ueda MT, Nakagawa S, Beck S, Bahram S, Takehara K, Sato S, Ihn H. RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis. J Invest Dermatol. 2017 Sep;137(9):1878-1886.
  6. Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y*. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017 Jun;76(6):1150-1158.
  7. Ogawa TOkiyama N*, Koguchi-Yoshioka H, Fujimoto M. Eosinophilic granulomatosis with polyangiitis followed by venous thromboembolism resulting in severe cutaneous ulcers. J Dermatol. 2017 Sep;44(9):e216-e217.
  8. Koguchi-Yoshioka HOkiyama N*Iwamoto K, Matsumura Y, Ogawa T, Inoue S, Watanabe R, Fujimoto M. Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules. Br J Dermatol. 2017 Nov;177(5):1442-1446.
  9. Kubota N, Ito M, Sakauchi M, Kobayashi K*. Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis. J Dermatol. 2017 Jul;44(7):e180-e181.
  10. Shibao K, Fujisawa Y*, Nakamura Y, Nakamura Y, Maruyama H, Furuta JI, Okiyama N, Ishii Y, Fujimoto M. Cutaneous squamous cell carcinoma treated with preoperative intraarterial chemoradiation therapy. J Dtsch Dermatol Ges. 2017 Jul;15(7):724-726.
  11. Togawa R, Tanino Y*, Nikaido T, Fukuhara N, Uematsu M, Misa K, Sato Y, Matsuda N, Sugiura Y, Namatame S, Kobayashi H, Hamaguchi Y, Fujimoto M, Kuwana M, Munakata M.Three cases of interstitial pneumonia with anti-signal recognition particle antibody. Allergol Int. 2017 Jul;66(3):485-487.
  12. Iwamoto KIshitsuka Y*, Tanaka R, Sekine I, Fujimoto M. Azathioprine combination therapy for steroid-refractory hepatic immune system-related adverse events. Eur J Dermatol. 2017 Jun 1;27(3):301-303.
  13. Saito A, Okiyama N*, Saito K, Tanaka R, Maruyama H, Fujimoto M, Case of facial lupus erythematosus profundus with intractable ulceration successfully treated with dapsone. J Dermatol. 2017 May;44(5):e89-e90.
  14. Tanaka R, Okiyama N*Okune M, Ishitsuka Y, Watanabe R, Furuta J, Ohtsuka M, Otsuka A, Maruyama H, Fujisawa Y, Fujimoto M, Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab reactivity. J Dermatol Sci. 2017 Apr;86(1):71-73.
  15. Ogawa TOkiyama N*, Koguchi-Yoshioka H, Fujimoto M, Taxane-induced scleroderma-like skin changes resulting in gangrene: A case report. J Dermatol. 2017 Apr;44(4):e54-e55.
  16. Maruyama H*, Tanaka R, Fujisawa Y, Nakamura Y, Ito S, Fujimoto M. Availability of sentinel lymph node biopsy for cutaneous squamous cell carcinoma. J Dermatol. 2017 Apr;44(4):431-437.
  17. Matsushita T*, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi YO, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K. Anti-MDA5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol. 2017 Feb;176(2):395-402.
  18. Nakamura Y*, Tanaka R, Asami Y, Teramoto Y, Imamura T, Sato S, Maruyama H, Fujisawa Y, Matsuya T, Fujimoto M, Yamamoto A. Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi-institutional retrospective study. J Dermatol. 2017 Feb;44(2):117-122.
  19. Inoue S, Okiyama N*, Okune M, Shiraki N, Kessoku R, Fujimoto M, Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works. J Dermatol. 2017 Jan; 44(1):84-87
  20. Hasegawa H, Kawahata K, Mizoguchi F, Okiyama N, Miyasaka N, Kohsaka H*, Direct suppression of autoaggressive CD8+ T cells with CD80/86 blockade in CD8+ T cell-mediated polymyositis models of mice. Clin Exp Rheumatol. 2017 Jan 27.

著書・総説
  1. 沖山奈緒子「特集:免疫チェックポイント阻害薬:免疫学から理解する副作用 皮膚症状とIL-6」Keynote RA Vol.5 No.3、先端医学社、2017年12月25日
  2. 厚生労働科学研究費補助金難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班 診療ガイドライン作成委員会(委員:藤本 学、沖山奈緒子、他)「成人スチル病診療ガイドライン 2017年版」、診断と治療社、2017年11月30日
  3. 藤澤康弘「見逃してはいけない皮膚悪性腫瘍」、渡辺 玲「乾癬治療の最前線」Mebio Graphic Medical Magazine Vol.34 No.10、メディカルレビュー社、2017年10月10日
  4. 渡辺 玲「ヒト皮膚resident memory T細胞」皮膚アレルギーフロンティア Vol.15 No.2、メディカルレビュー社、2017年7月15日
  5. 沖山奈緒子「エリテマトーデスをきわめる─SLEエンサイクロペディア ▼Part2. 非特異的皮疹 case 16 口腔内潰瘍」Visual Dermatology Vol.16 No.8、学研メディカル秀潤社、2017年7月25日
  6. 沖山 奈緒子, 田中 亮多「特集:がん免疫チェックポイント阻害剤の免疫性副作用 免疫チェックポイント阻害剤によって誘発される多彩な自己免疫反応性副作用 — interleukin-6を介する乾癬様皮膚炎を中心に —」日本臨床免疫学会会誌 40 巻 (2017) 2 号 p. 95-101、2017年6月12日
  7. 沖山奈緒子専門医でも聞きたい 皮膚科診療100の質問 膠原病55 皮膚筋炎は抗体プロフィールで治療方針が変わる?」メディカルレビュー社、2017年6月10日
  8. 沖山奈緒子「特集 膠原病はどこまでわかったか? 皮膚筋炎・多発性筋炎の発症メカニズム」皮膚アレルギーフロンティア Vol.15 No.1、メディカルレビュー社、2017年3月15日
  9. 沖山奈緒子「特集 厚生労働省指定難病の診断基準と重症度 全身性強皮症」分子リウマチ治療第10巻第1号、先端医学社、2017年1月20日
  10. 藤本 学「VII 膠原病および類似疾患 5 限局性強皮症」、沖山奈緒子「VI 紫斑、血管炎 11 好酸球性多発血管炎性肉芽腫症・多発血管炎性肉芽腫症」、渡辺 玲「XVI 感染症 D リケッチア、寄生虫 6 虫刺症」、皮膚疾患最新の治療2017-2018、南江堂、2017年1月30日

2016年


論文
  1. Fujimoto M*, Murakami A, Kurei S, Okiyama N, Kawakami A, Mishima M, Sato S, Seishima M, Suda T, Mimori T, Takehara K, Kuwana M.Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. J Dermatol Sci. 2016 Dec;84(3):272-281.
  2. Takeuchi A, Matsushita T, Kaji K, Okamoto Y, Yasui M, Hirata M, Oishi N, Higashi A, Seishima M, Asano T, Fujimoto M, Kuwana M, Takehara K, Hamaguchi Y*. Autoantibody to scaffold attachment factor B (SAFB): A novel connective tissue disease-related autoantibody associated with interstitial lung disease. J Autoimmun. 2016 Sep; 76:101-107.
  3. Ang CC, Anyanwu CO, Robinson E, Okawa J, Feng R, Fujimoto M, Hamaguchi Y, Werth VP*. Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis. Br J Dermatol. 2016 Jun 13
  4. Fujimoto M*, Watanabe R, Ishitsuka Y, Okiyama N. Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatology. 2016 Nov;28(6):636-644.
  5. Matsushita T*, Le Huu D, Kobayashi T, Hamaguchi Y, Hasegawa M, Naka K, Hirao A, Muramatsu M, Takehara K, Fujimoto M. A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation. J Allergy Clin Immunol. 2016 Oct. 138(4):1170-1182.
  6. Ohara K, Fujisawa Y*, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Yoshimura K, Fujimoto M. A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors. J Dermatol Sci. 2016 Sep;83(3):234-239
  7. Shibao K, Okiyama N*, Tanaka R, Maruyama H, Fujisawa Y, Fujimoto M. Nodulocystic basal cell carcinoma arising directly from a seborrheic keratosis: a rare case report. Indian J Dermatol. 2016 Jul-Aug; 61(4): 443-445.
  8. Saito KOkiyama N*, Shibao K, Maruyama H, Fujimoto M. Angioimmunoblastic T-cell lymphoma mimicking dermatomyositis. J Dermatol. 2016 Jul; 43(7):837-839.
  9. Tanaka R*, Sasajima Y, Tsuda H, Namikawa K, Takahashi A, Tsutsumida A, Fujisawa Y, Fujimoto M, Yamazaki N. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease. Clin Exp Metastasis. 2016 Jul.
  10. Shibao K, Okiyama N*, Maruyama H, Furuta J, Fujimoto M. Scleroderma-like skin changes occurring after the use pf paclitaxel without any chemical solvents: a first case report. Eur J Dermatol. 2016 Jun; 26(3):317-318
  11. Tanaka R*Fujisawa Y, Maruyama H, Nakamura Y, Yoshino K, Ohtsuka M, Fujimoto M. Nivolumab-induced tyroid dysfunction. Jpn J Clin Oncol. 2016 Jun;46(6):575-9.
  12. Mugii N, Hasegawa M*, Matsushita T, Hamaguchi Y, Oohata S, Okita H, Yahata T, Someya F, Inoue K, Murono S, Fujimoto M, Takehara K. Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. PLoS One. 2016 May 11;11(5):e0154746.
  13. Saito A, Okiyama N*, Maruyama H, Fujimoto M, Immunogloblin A vasculitis associated with HIV infection,  J Dermatol. 2016 Apr; 43(4):444-445
  14. Sato S, Murakami A, Kuwajima A, Takehara K, Mimori T, Kawakami A, Mishima M, Suda T, Seishima M, Fujimoto M, Kuwana M*. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies. PLoS One. 2016 Apr 26;11(4):e0154285.
  15. Furukawa H*, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N. Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01. PLoS One. 2016 Apr 26;11(4):e0154255.
  16. Yang L, Murota H*, Shindo S, Yang F, Serada S, Fujimoto M, Naka T, Katayama I. Increased serum CXCR2 ligand levels in livedo vasculopathy with winter ulcerations: Possible contribution of neutrophil recruitment to lesional skin. J Dermatol Sci. 2016 Apr;82(1):57-9.
  17. Matsushita T*, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity. Rheumatology (Oxford). 2016 Feb; 55(2):263-7

著書・総説
  1. 沖山奈緒子、第4章 皮膚疾患の基礎知識「27 シェーグレン症候群」、マイスターから学ぶ 皮膚科治療薬の服薬指導術、メディカルレビュー社、2016年11月10日
  2. 沖山奈緒子、藤本 学、「皮膚硬化 治療法の選択」、強皮症の基礎と臨床 病態の解明から最新の診療まで、医薬ジャーナル社、2016年8月20日
  3. 沖山奈緒子、「ステロイド」皮膚科内服剤の使用法と留意点、Monthly Book Derma. No. 246、全日本病院出版会、2016年7月15日
  4. 沖山奈緒子、「新しい膠原病治療薬と今後の展望」皮膚科の薬剤と医療機器~最近10年間の進歩、皮膚科の臨床5月臨時創刊号 58(6)、金原出版、2016年5月31日
  5. 藤本 学、「A リウマチ性疾患へのアプローチ 12 リウマチ性疾患の皮膚病変のみかた」リウマチ病学テキスト改訂第2版、診断と治療社、2016年1月5日

2015年


論文
  1. Kishi T*, Miyamae T, Morimoto R, Ishiguro N, Hamaguchi Y, Fujimoto M, Nagata S, Yamanaka H. Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study. Pediatr Dermatol. 2015 Sep-Oct;32(5):e224-5.
  2. Sato S, Nakamura Y, Teramoto Y, Yeh YW, Maruyama H, Nakamura Y*, Fujisawa Y, Fujimoto M, Yamamoto A. A novel approach for inguinal lymph node dissection without inguinal skin incision for invasive extramammary Paget disease. Dermatol Ther. 2015 Nov;28(6):351-4. 
  3. Nakamura Y*, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, Fujimoto M, Otsuka F, Hayashi N, Yamazaki N, Yamamoto A. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015 Sep;42(9):861-6.
  4. Miyagaki T, Fujimoto M, Sato S*. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research. Int Immunol. 2015 Nov;27(10):495-504.
  5. Hamaguchi Y, Matsushita T, Hasegawa M, Ueda-Hayakawa I, Sato S, Takehara K, Fujimoto M*. High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies. Mod Rheumatol. 2015 Sep;25(5):798-801.
  6. Nakamura Y*, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, Fujimoto M, Otsuka F, Hayashi N, Yamazaki N, Yamamoto A. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015 Sep;42(9):861-6
  7. Okiyama N, Hasegawa H, Oida T, Hirata S, Yokozeki Y, Fujimoto M, Miyasaka N and Kohsaka H*, Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide, Int Immunol.  2015 Jul;27(7):327-32.
  8. Fujisawa Y*, Yoshino K, Kiyohara Y, Kadono T, Murata Y, Uhara H, Hatta N, Uchi H, Matsushita S, Takenouchi T, Hayashi T, Fujimoto M, Ohara K. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget’s disease: Multi-center, retrospective study of 151 patients. J Dermatol Sci. 2015 Jul;79(1):38-42
  9. Okiyama N*, Fujimoto M, Clinical perspective and murine models of lichenoid tissue reaction/interface dermatitis. J Dermatol Sci. 2015 Jun;78(3):167-172
  10. Tsuji G, Okiyama N, Villarroel VA, Katz SI*, Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation. J Allergy Clin Immunol. 2015 May;135(5):1228-1239
  11. Hamaguchi Y, Kodera M, Matsushita T, Hasegawa M, Inaba Y, Usuda T, Kuwana M, Takehara K, Fujimoto M*. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies. Arthritis Rheumatol. 2015 Apr;67(4):1045-52.
  12. Yang L, Fujimoto M, Murota H, Serada S, Fujimoto M, Honda H, Yamada K, Suzuki K, Nishikawa A, Hosono Y, Yoneda Y, Takehara K, Imura Y, Mimori T, Takeuchi T, Katayama I, Naka T*. Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud’s phenomenon. Rheumatology (Oxford). 2015 Feb;54(2):349-58.
  13. Horai Y*, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Ida H, Kakugawa T, Sakamoto N, Ishimatsu Y, Mukae H, Hamaguchi Y, Fujimoto M, Kuwana M, Origuchi T, Kohno S, Kawakami A. Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Mod Rheumatol. 2015 Jan;25(1):85-9.
  14. Kubota N, Fujisawa Y*, Nakamura Y, Tanaka R, Saito A, Maruyama H, Ishii Y, Furutra J, Kawachi Y, Fujimoto M. Angiosarcoma of the scalp in a patient with systemic sclerosis. J Dermatol. 2015 Jan;42(1):102-4.

論文
  1. 沖山奈緒子、古田淳一、藤本 学、【全身性強皮症とその鑑別疾患-より早期に、正確に診断するために】 (Part2.)皮膚硬化を来す疾患(case 02) 好酸球性(びまん性)筋膜炎、Visual Dermatology15巻1号、2015年12月
  2. 沖山奈緒子、藤本 学、「3章 眼瞼腫脹を来す疾患(アレルギー疾患以外) 3 皮膚筋炎」皮膚科・眼科の連携マニュアル 目の周りの病気とその治療、秀潤社、2015年12月31日
  3. 厚生労働省科学研究補助金 難治性疾患等政策研究事業 自己免疫疾患に関する調査研究班 多発性筋炎・皮膚筋炎分科会(藤本 学:分科会委員)、「多発性筋炎・皮膚筋炎 治療ガイドライン」、診断と治療社、2015年12月14日
  4. 古田 淳一、「症例6 体幹の痒い発疹」「症例10 全身に多発する白斑」「症例23 全身の紅斑,口唇のびらん」「症例24 全身の紅斑,口囲の膿疱」「症例25 全身の紅斑,水疱,びらん」「症例26 全身の鱗屑を伴う紅斑」【皮膚診療ができる!診断と治療の公式44】レジデントノート17巻14号、羊土社、2015年12月10日
  5. 沖山奈緒子、「膠原病の皮膚病変のみかた」内科医が診る皮膚疾患 -専門医はこう鑑別・治療している!今日から使えるポイントとコツー、Mebio Graphic Medical Magagine Vol. 32 No.11、メジカルビュー社、2015年11月10日
  6. 沖山奈緒子、「エリテマトーデスの診断基準と病型分類」Monthly Book Derma. No. 235、全日本病院出版会、2015年9月15日
  7. 沖山奈緒子、藤本 学、「2章 小児皮膚アトラス 57 皮膚筋炎」小児を診る! 皮膚科医の心得、皮膚科の臨床5月増刊号 Vol. 57 No.6、金原出版、2015年5月29日
  8. 古田 淳一、「アトピー性皮膚炎のマネージメントの実際」【いまどうなっている?アトピー性皮膚炎】、Mebio Graphic Medical Magagine Vol. 32 No.4、メジカルビュー社、2015年4月10日

2014年


論文
  1. Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y, Fujimoto M. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. Br J Dermatol. 2014 Dec;171(6):1493-500.
  2. Nakamura Y, Shimizu M, Fujisawa Y, Taguchi S, Nakamura Y, Teramoto Y, Sato S, Yamamoto A. Pedunculated dermatofibrosarcoma protuberans: an unusual presentation. J Dtsch Dermatol Ges. 2014 Dec;12(12):1132-4.
  3. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014 Nov;184(11):3120-9.
  4. Nakamura Y, Teramoto Y, Tanaka R, Nakamura Y,Maruyama H, Fujisawa Y, Sato S, Fujimoto M,Yamamoto A. Surgical management of umbilical basal cell carcinoma: Published work review and the optimal depth of surgical excision. J Dermatol. 2014 Nov;41(11):992-5.
  5. Kabuto M, Fujimoto N, Teramura K, Tateishi M, Hamaguchi Y, Fujimoto M, Tanaka T. A case of dermatomyositis with esophageal fistula in whom blind mucosal biopsy detected occult oropharyngeal carcinoma. Case Rep Dermatol. 2014 Nov 20;6(3):268-73.
  6. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience. J Dermatolog Treat. 2014 Oct;25(5):419-23.
  7. Nakamura Y, Fujisawa Y, Teramoto Y, Sato S, Yamada K, Sekine K, Fujimoto M, Otsuka F, Yamamoto A. Tumor-to-bone distance of invasive subungual melanoma: an analysis of 30 cases. J Dermatol. 2014 Oct;41(10):872-7.
  8. Okiyama N, Katz SI*. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes. J Autoimmun. 2014 Sep;53:1-9.
  9. Nakamura Y, Teramoto Y, Sato S, Yamada K, Nakamura Y, Fujisawa Y, Fujimoto M, Otsuka F, Yamamoto A. Axillary giant lipoma: a report of two cases and published work review. J Dermatol. 2014 Sep;41(9):841-4.
  10. Yamaoka T, Doi C, Yokomi A, Tanemura A, Murota H, Tani M, Saruban H, Hamaguchi Y, Fujimoto M, Katayama I. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer. Eur J Dermatol. 2014 Jul-Aug;24(4):490-1.
  11. Miyake M, Sakai A, Nishijima C, Kita T, Nitta E, Kawashima A, Hamaguchi Y, Fujimoto M, Inaoki M. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease. J Dermatol. 2014 Jul;41(7):664-5.
  12. Oishi K, Hamaguchi Y, Matsushita T, Hasegawa M, Okiyama N, Dernedde J, Weinhart M, Haag R, Tedder TF, Takehara K, Kohsaka H, Fujimoto M. A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheum. 2014 Jul;66(7):1864-71.
  13. Fujimoto N, Takayama S, Hamaguchi Y, Fujimoto M, Tanaka T. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis. Acta Derm Venereol. 2014 Jul;94(4):478-9.
  14. Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI, CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease. J Invest Dermatol. 2014 Jun;134(6):1552-60.
  15. Le Huu D, Kimura H, Date M, Hamaguchi Y, Hasegawa M, Hau KT, Fujimoto M, Takehara K, Matsushita T. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease. J Dermatol Sci. 2014 Jun;74(3):214-21.
  16. Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J,  Sekido M, Kawachi Y. B-Myb enhances proliferation and suppresses differentiation of keratinocytes in three-dimensional cell culture. Arch Dermatol Res. 2014 May;306(4):375-84.
  17. Fujisawa Y, Maruyama H, Furuta J, Ishii Y, Kawachi Y, Fujimoto M. Case of pigmented epithelioid melanocytoma with lymph node metastases. J Dermatol. 2014 May;41(5):452-3.
  18. Fujimoto N, Honda S, Wakabayashi M, Hamaguchi Y, Fujimoto M, Tanaka T. Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease. Mod Rheumatol. 2014 May 20:1-3.
  19. Fujisawa Y, Furuta J, Kawachi Y. Dermatofibrosarcoma protuberans mimicking cutaneous sarcoidosis in a patient with lung sarcoidosis. Eur J Dermatol. 2014 Mar-Apr;24(2):276-7.
  20. Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O’Shea JJ and Katz SI, Reversal of CD8 T cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor, tofacitinib, J Invest Dermatol. 2014 Apr:134(6):992-1000
  21. Kaji K, Fertig N, Medsger TA Jr, Satoh T, Hoshino K, Hamaguchi Y, Hasegawa M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fujimoto M, Kuwana M. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Arthritis Care Res (Hoboken). 2014 Apr;66(4):575-84.
  22. Hatta Y, Hasegawa M, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients. Mod Rheumatol. 2014 Mar;24(2):377-9.
  23. Fujisawa Y, Fujimoto M. Metastatic cutaneous apocrine carcinoma of the axilla successfully treated using systemic chemotherapy with i.v. epirubicin and cyclophosphamide followed by oral fluorinated pyrimidine. J Dermatol. 2014 Mar;41(3):280-2.
  24. Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y, Sakata S, Kamada Y, Nakamoto-Matsubara R, Tran NB, Izutsu K, Sato Y, Ohta Y, Furuta J, Shimizu S, Komeno T, Sato Y, Ito T, Noguchi M, Noguchi E, Sanada M, Chiba K, Tanaka H, Suzukawa K, Nanmoku T, Hasegawa Y, Nureki O, Miyano S, Nakamura N, Takeuchi K, Ogawa S, Chiba S. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014 Feb;46(2):171-5.
  25. Araki Y, Ishii Y, Abe Y, Yoshizawa J, Okamoto F, Hozumi Y, Suzuki T. Hermansky-Pudlak syndrome type 4 with a novel mutation. J Dermatol. 2014 Feb;41(2):186-7.
  26. Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. PLoS One. 2014 Feb 6;9(2):e88150.

2013年


論文
  1. Ueda-Hayakawa I, Kusuyama T, Isei T, Ozaki Y, Hamaguchi Y, Fujimoto M, Takehara K, Okamoto H. Cutaneous necrotizing vasculitis in a patient with dermatomyositis positive for anti-PL-7 antibody. Eur J Dermatol. 2013 Nov-Dec;23(6):889-90.
  2. Miyagawa F, Okiyama N, Villarroel VA, Katz SI, Identification of CD3+CD4CD8 T cells as potential regulatory cells in an experimental murine model of graft-versus-host disease (GVHD). J Invest Dermatol. 2013 Nov:133(11):2538-2545
  3. Fujisawa Y, Miyazono Y, Kawachi Y, Otsuka F. A case of sterile transient neonatal pustulosis presenting with large flaccid pustules. Pediatr Dermatol. 2013 Nov-Dec;30(6):e238-9.
  4. Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K. Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study. Mod Rheumatol. 2013 Nov;23(6):1076-84.
  5. Kasuya A, Hamaguchi Y, Fujimoto M, Tokura Y. TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody. Acta Derm Venereol. 2013 Nov;93(6):715-6.
  6. Nakamura Y, Nakamura Y, Saito A, Fujisawa Y, Kawachi Y, Otsuka F. High-grade mucoepidermoid carcinoma of the columella successfully reconstructed using bilateral nasolabial flaps set up in a sandwich shape and an auricular cartilage graft after surgical resection. J Dermatol. 2013 Nov;40(11):911-4.
  7. Ishitsuka Y, Kawachi Y, Maruyama H, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F, .Pituitary tumor transforming gene 1 induces tumor necrosis factor-α production from keratinocytes: implication for involvement in the pathophysiology of psoriasis. J Invest Dermatol. 2013 Nov;133(11):2566-75.
  8. Hasegawa M, Hatta Y, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis. Mod Rheumatol. 2013 Sep;23(5):913-9.
  9. Hamaguchi Y, Fujimoto M, Oishi K, Kitajima S, Wada T, Takehara K. Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept. Eur J Dermatol. 2013 Sep-Oct;23(5):700-1.
  10. Taguchi S, Kawachi Y, Fujisawa Y, Nakamura Y, Furuta J, Otsuka F. Psoriasiform eruption associated with graft-versus-host disease. Cutis. 2013 Sep;92(3):151-3.
  11. Kawachi Y, Obara S, Nakamura Y, Fujisawa Y, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. Ischemic leg ulcer due to vasculopathy associated with neurofibromatosis type 1. Eur J Dermatol. 2013 Jul-Aug;23(4):522-3.
  12. Nakamura Y, Kawachi Y, Nakamura Y, Iino Y, Fujisawa Y, Otsuka F. Linear lupus erythematosus profundus involving the muscle with an intractable deep ulcer, successfully treated with surgical excision. Eur J Dermatol. 2013 Jul-Aug;23(4):535-6.
  13. Ito K, Imafuku S, Hamaguchi Y, Fujimoto M, Nakayama J. Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol. 2013 Jul;40(7):567-9. 
  14. Kawachi Y, Ishitsuka Y, Maruyama H, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. The POU domain transcription factors Oct-6 and Oct-11negatively regulate loricrin gene expression in keratinocytes: association with AP-1 and Sp1/Sp3. Arch Dermatol Res. 2013 Jul;305(5):371-8.
  15. Huu DL, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. Arthritis Rheum. 2013 Jun;65(6):1624-35.
  16. Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol. 2013 Jun;131(6):1674-82.
  17. Nakamura Y, Fujisawa Y, Nakamura Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F. Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer. J Dermatol. 2013 Jun;40(6):453-7.
  18. Maruyama H, Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Penile preservation surgery in a case of erythroplasia of Queyrat involving the glans penis and distal urethra. Int J Dermatol. 2013 May 15.
  19. Nakamura Y, Iino Y, Nakamura Y, Fujisawa Y, Kawachi Y, Otsuka F. Intraneural granular cell tumor of the dorsal ramus of a thoracic nerve. Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):258-60.
  20. Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013 Apr 18;121(16):3274-83.
  21. Hara S, Henmi T, Kawakami A, Fujikawa K, Mukae H, Ishimatsu Y, Sakamoto N, Kakugawa T, Kaji K, Fujimoto M, Kuwana M, Tsukada T, Satoh K, Motomura M, Tamai M, Nakamura H, Ida H, Hayashi T, Origuchi T, Eguchi K, Kohno S. Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population. Rheumatol Int. 2013 Apr;33(4):1059-64.
  22. Hasegawa M, Higashi K, Matsushita T, Hamaguchi Y, Saito K, Fujimoto M, Takehara K. Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. J Dermatol Sci. 2013 Apr;70(1):34-41.
  23. Kawachi Y, Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Ichikawa E, Furumura M, Otsuka F. NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells. Exp Dermatol. 2013 Apr;22(4):262-5.
  24. Kawashima H, Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F. Circumscribed palmar hypokeratosis: implication of suppression of early epidermal differentiation. Eur J Dermatol. 2013 Apr 1;23(2):261-2.
  25. Arai M, Ikawa Y, Chujo S, Hamaguchi Y, Ishida W, Shirasaki F, Hasegawa M, Mukaida N, Fujimoto M, Takehara K. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. J Dermatol Sci. 2013 Mar;69(3):250-8.
  26. Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2013 Feb;52(2):242-51.
  27. Hasegawa M, Imura-Kumada S, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis. J Dermatol. 2013 Feb;40(2):89-93.
  28. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Docetaxel was effective in the management of metastatic angiosarcoma associated with disseminated intravascular coagulation syndrome. Int J Dermatol. 2014 Feb;53(2):e138-40.
  29. Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Okamoto Y, Hasegawa M, Fujimoto M, Ihn H. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3. Am J Pathol. 2013 Jan;182(1):206-16.
  30. Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, Yamaoka T, Fujikawa K, Tsukada T, Sato K, Echigo T, Hasegawa M, Takehara K. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis. 2013 Jan;72(1):151-3.
  31. Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases. Mod Rheumatol. 2013 Jan;23(1):190-4.
  32. Ueda-Hayakawa I, Hasegawa M, Hamaguchi Y, Takehara K, Fujimoto M. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. J Dermatol Sci. 2013 Jan;69(1):54-60. 
  33.  Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013;8(4):e60442.

2012年


論文
  1. Fujisawa Y, Otsuka F : The benefit of sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multi-center, retrospective study of 291 Japanese patients Melanoma Res 22(5): 362-367, 2012
  2. Okiyama N, Sugihara T, Oida T, Ohata J, Yokozeki H, Miyasaka N, Kohsaka H. T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model. Arthritis Rheum. 2012 Nov:64(11):3741-9
  3. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F : Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer J Surg Oncol 106(1):41-45, 2012
  4. Nakamura Y, Nakamura Y, Ishitsuka Y, Maruyama H, Fujisawa Y, Kawachi Y, Otsuka F : Facial nerve morbidity following facial nerve preservation surgery for the treatment of skin cancer of the head and neck J Eur Acad Dermatol Venereol 26 (10): 1323-1325, 2012
  5. Ishitsuka Y, Kawachi Y, Taguchi S, Maruyama H, Fujisawa Y, Furuta J, Nakamura Y, Otsuka F : Pituitary tumor-transforming gene 1 enhances proliferation and suppresses early differentiation of keratinocytes J Invest Dermatol 132 (7): 1775-1784, 2012
  6. Nakamura Y, Fujisawa Y, Ishikawa M, Nakamura Y, Ishitsuka Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F : Usefulness of sentinel lymph node biopsy for extramammary Paget disease Br J Dermatol 167 (4):954-956, 2012
  7. Kawachi Y, Furuta J, Fujisawa Y, Nakamura Y, Ishii Y, Otsuka F : Indolent subcutaneous panniculitis-like T cell lymphoma in a 1-year-old child Pediatr Dermatol 29 (3): 374-347, 2012
  8. Nakamura Y, Shibata-Ito M, Nakamura Y, Ishitsuka Y, Fujisawa Y, Kawachi Y, Otsuka F : Malignant blue nevus arising in a giant congenital cellular blue nevus in an infant Pediatr Dermatol 29(5):651-655, 2012
  9. Ishitsuka Y, Furuta J, Miyashita T, Otsuka F : Splicing aberration in naevoid basal cell carcinoma syndrome Acta Derm Venereol 92 (6): 619-620, 2012
  10. Nakamura Y, Satomi K, Noguchi M, Shibata-Ito M, Fujisawa Y, Kawachi Y, Otsuka F : Incidental Gastric Signet-ring Cell Carcinoma Metastasis to the Skin in Basal Cell Carcinoma Acta Derm Venereol 92(6):635-636, 2012
  11. Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Pruritic poikilodermatous eruption associated with dermatomyositis: successful treatment with dapsone Eur J Dermatol 22 (2): 289-290, 2012
  12. Nakamura Y, Nakamura Y, Fujisawa Y, Obara S, Furuta J, Kawachi Y, Otsuka F : Multiple inguinal and pelvic lymph node metastases of malignant melanoma of the heel identified by common iliac lymphadenopathy Lymphat Res Biol 10 (3):118-121, 2012
  13. 前田麻衣子,古田淳一,多島新吾,大塚藤男 : 抗てんかん薬臭化カリウム内服により生じたBromoderma 皮膚臨床 54 (2): 233-236,165-166, 2012
  14. 田中亮多,石井良征,中村貴之,中村泰大,川内康弘,大塚藤男 : 両下顎に硬結性局面を生じた白癬菌性毛瘡の1例 皮膚臨床 54 (2): 245-248, 2012
  15. 藤澤康弘,大塚藤男,山本明史,山﨑直也,斎田俊明,石原和之 : 本邦における悪性黒色腫の統計:2006,2007年度全国定点調査と2005~2010年度全国追跡調査の集計 Skin Cancer. 27 (2): 195-204, 2012
  16. 前田麻衣子,古田淳一, 多島新吾,大塚藤男 : Papular Purpuric Gloves and Socks Syndrome 皮膚臨床 54 (8): 1070-1074, 2012
  17. 久保田典子,古田淳一,大塚藤男,狩野俊幸 : 肺結核に併発したSweet病 皮膚病診療 34 (8): 767-770, 2012
  18. 藤澤康弘,大塚藤男 : 術後補助療法(DAVFeron、フェロン療法、フェロン維持療法)は悪性黒色腫ステージⅡ・Ⅲ患者の予後を改善するか:831例の解析 日皮会誌 122 (9): 2305-2311, 2012
  19. 宮崎郁,古田淳一,小林桂子,川内康弘,大塚藤男 : 好酸球増多症を伴ったBuerger病 皮膚病診療 34 (11): 1107-1110, 2012
  20. 藤澤康弘,中村泰大,丸山浩,中村貴之,川内康弘,大塚藤男 : インドシアニングリーンを用いた蛍光法によるセンチネルリンパ節生検50例のまとめ 日皮会誌 122 (12): 2875-2884, 2012
  21. 石塚洋典,川内康弘,藤澤康弘,田口詩路痲,大塚藤男 : pituitary tumor transforming gene 1の表皮細胞の分化における役割 第26回角化症研究会記録集 12-16, 2012

2011


論文
  1. Taguchi S, Kawachi Y, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Xu X, Ikebe D, Kato M, Otsuka F: Overexpression of the transcription factor Yin-Yang-1 suppresses differentiation of HaCaT cells in three-dimensional cell culture J Invest Dermatol,131 (1): 37-45, 2011
  2. Okiyama N, Kitajima T, Ito Y, Yokozeki H, Miyasaka N, Kohsaka H. Assition of the collagen binding domain of ficronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing. J Dermatol Sci 61(3): 215-217, 2011
  3. Fujisawa Y, Nabekura T, Nakamura Y, Furuta J, Ishii Y, Kawachi Y, Otsuka F, Onodera M : The enforced expression of RORgammat in hematopoietic stem cells increased Treg cells resulting in in vivo immune balance skewed to declined immunoreactivity Asian Pac J Allergy Immunol. 29 (1): 86-93, 2011
  4. Fujisawa Y, Ito M, Mori K, Okada S, Nakamura Y, Kawachi Y, Otsuka F : Intra-arterial mitoxantrone/paclitaxel in angiosarcoma of the lower limb associated with chronic lymphedema (Stewart-Treves syndrome) in a patient with cervical cancer: a case report Eur J Dermatol 21 (1): 119-120, 2011
  5. Kawachi Y, Tanaka R, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Superficial malignant peripheral nerve sheath tumor arising from a solitary cutaneous neurofibroma in a non-NF1 patient Eur J Dermatol 21 (1): 125-126, 2011
  6. Kawachi Y, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Linear childhood discoid lupus erythematosus following the lines of blaschko: successfully treated with topical tacrolimus Pediatr Dermatol, 28 (2): 205-207, 2011
  7. Kawachi Y, Hirota A, Otsuka F : Acceleration of UVB-induced photoaging in nrf2 gene- deficient mice Photomed Photobiol 33: 23-24, 2011
  8. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F : A handmade, low-cost intraoperative fluorescence navigation system with indocyanicne green for sentinel lymph node biopsy in skin cancer Dermatology. 222 (3): 261-268, 2011
  9. Ishitsuka Y, Ohara K, Otsuka F : Atypical fibrous histiocytoma of the skin with necrobiotic granuloma-like features. Acta Derm Venereol 91(4): 482-483, 2011
  10. Nakayama M, Tabuchi K, Nakamura Y, Hara A : Basal cell carcinoma of the head and neck J Skin Cancer. 2011;2011:496910.
  11. Nakamura Y, Fujisawa Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F : Intraoperative mapping with isosulfan blue of lymphatic leakage during inguinal lymph node dissection (ILND) for skin cancer for the prevention of postoperative lymphocele J Surg Oncol 104 (6): 657-660, 2011
  12. Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Otsuka F : Superficial epithelioma with sebaceous differentiation: immunohistochemical study of keratinocyte differentiation markers. Eur J of Dermatol 21 (6): 1016-1017, 2011
  13. Fujisawa Y, Sugita S, Kawachi Y, Otsuka F : A case of extra-abdominal desmoid tumor in the subcutis of the thigh J Dermatol 38 (8): 810-812, 2011
  14. 丸山浩,中村泰大,藤澤康弘,川内康弘,大塚藤男 : Malignant peripheral nerve sheath tumorの3例 日レ病学誌 2 (1): 81-84, 2011
  15. 宮崎郁,丸山浩,古田淳一,川内康弘,大塚藤男 : Schweninger-Buzzi型特発性斑状皮膚萎縮症 皮膚病診療 33 (1): 71-74, 2011
  16. 古田淳一,石井良征,大塚藤男 : イミキモド外用で治療した尖圭コンジローマ 皮膚病診療 33 (1): 39-42, 2011
  17. 鬼澤沙織,石川雅士,永江美香子,古田淳一 : 化学療法の爪障害に対するアクリル人工爪治療 皮膚病診療 33 (3): 295-298, 2011
  18. 前田麻衣子,古田淳一,大塚藤男,千貫祐子,森田栄伸 : アスピリンと運動により増強し,前投与薬により抑制できた小麦による蕁麻疹 皮膚病診療 33 (5): 531-532, 2011
  19. 前田麻衣子,古田淳一,大塚藤男 : 胸部と腹部に生じたMondor病 皮膚病診療 33 (9): 901-904, 2011
  20. 前田麻衣子,古田淳一,伴野朋裕,多島新吾,大塚藤男,山田信博 : 皮膚黄色腫症を契機に診断した原発性高コレステロール血症の幼児例 皮膚臨床 53 (13): 1931-1935, 1853-1854, 2011
  21. 下條信威,越田隆介,斉藤明允,中村泰大,萩谷圭一,西野衆文,安田貢,河野了,水谷太郎 : 重症熱傷に合併したDIC症例に対してトロンボモデュリンアルファを使用した一例 Thrombosis Medicine 1(2): 219-223, 2011
  22. 中村泰大,藤澤康弘,丸山浩,中村貴之,古田淳一,川内康弘,大塚藤男 : 鼠径リンパ節郭清後リンパ漏予防のための術中パテントブルー注射による損傷リンパ管同定 日本皮膚外科学会雑誌16 (1): 78-79, 2011
  23. 中村貴之,中村泰大,藤澤康弘,石塚洋典,丸山浩,鬼澤沙織,川内康弘,大塚藤男 : 女性外陰部悪性腫瘍切除後欠損に対するV-Y advancement type gluteal fold flapの問題点に関する検討 日本皮膚外科学会雑誌16 (1): 68-70, 2011
  24. 鈴木麻衣子,古田淳一,大塚藤男 : ステロイド外用によるクッシング症候群を来した乾癬の2例 第25回日本乾癬学会記録集 230, 2011

総 説
  1. 藤澤康弘 : 皮膚科セミナリウム 悪性間葉系腫瘍 脈管系悪性腫瘍 日皮会誌. 121 (4): 3323-3329, 2011
  2. 中村泰大, 川内康弘 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION03)頭部の小結節 Visual Dermatol 10 (6): 561-562, 2011
  3. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION10)顔面の多発性丘疹・小結節 Visual Dermatol 10 (6): 567-568, 2011
  4. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part1)頭頸部~躯幹 (QUESTION16)外陰部周囲に多発する結節 Visual Dermatol 10 (6): 573-574, 2011
  5. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION35)体幹の多発性丘疹 Visual Dermatol 10 (6): 595-596, 2011
  6. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION36)背部に多発する赤褐色斑 Visual Dermatol 10 (6): 595-596, 2011
  7. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION38)背部の色素沈着 Visual Dermatol 10 (6): 597-598, 2011
  8. 中村泰大, 大原國章 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION39)臀部~大腿の茶褐色斑. Visual Dermatol 10 (6): 599-600, 2011
  9. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION40)腰部の軟らかい結節 Visual Dermatol 10 (6): 599-600, 2011
  10. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION41)手背~前腕の皮斑 Visual Dermatol 10 (6): 601-602, 2011
  11. 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION44)手背の褐色斑、脱色素斑 Visual Dermatol 10 (6): 603-604, 2011
  12. 梅林芳弘, 丸山浩, 中村泰大 : Snap diagnosisトレーニング帳 知らないとはずかしい皮膚疾患[番外編] (Part2)躯幹~四肢 (QUESTION50)踵内側の多発性丘疹 Visual Dermatol 10 (6): 609-610, 2011
  13. 井上雄二, 長谷川稔, 前川武雄, レパヴー・アンドレ, 浅野善英, 安部正敏, 石井貴之, 伊藤孝明, 爲政大幾, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 林昌浩, 藤本学, 藤原浩, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  創傷一般. 日皮会誌121 (8): 1539-1559, 2011
  14. 立花隆夫, 今福信一, 入澤亮吉, 大塚正樹, 門野岳史, 藤原浩, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 伊藤孝明, 井上雄二, 大塚幹夫, 小川文秀, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  褥瘡診療ガイドライン 日皮会誌 121 (9): 1791-1839, 2011
  15. 爲政大幾, 安部正敏, 中西健史, 松尾光馬, 山崎修, 浅野善英, 石井貴之, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 小寺雅也, 川上民裕, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 藤原浩, 前川武雄, 間所直樹, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  糖尿病性潰瘍・壊疽ガイドライン 日皮会誌 121 (10): 1997-2035, 2011
  16. 藤本学, 浅野善英, 石井貴之, 小川文秀, 川上民裕, 小寺雅也, 安部正敏, 爲政大幾, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 門野岳史, 川口雅一, 久木野竜一, 幸野健, 境恵祐, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 橋本彰, 長谷川稔, 林昌浩, 藤原浩, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  膠原病・血管炎にともなう皮膚潰瘍診療ガイドライン 日皮会誌 121 (11): 2187-2223, 2011
  17. 伊藤孝明, 久木野竜一, 高原正和, 谷岡未樹, 中村泰大, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 大塚幹夫, 小川文秀, 門野岳史, 川上民裕, 川口雅一, 幸野健, 小寺雅也, 境恵祐, 中西健史, 橋本彰, 長谷川稔, 林昌浩, 藤本学, 藤原浩, 前川武雄, 松尾光馬, 間所直樹, 山崎修, 吉野雄一郎, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  下腿潰瘍・下肢静脈瘤診療ガイドライン 日皮会誌 121 (12): 2431-2448, 2011
  18. 吉野雄一郎, 大塚幹夫, 川口雅一, 境恵祐, 橋本彰, 林昌浩, 間所直樹, 浅野善英, 安部正敏, 石井貴之, 爲政大幾, 伊藤孝明, 井上雄二, 今福信一, 入澤亮吉, 大塚正樹, 小川文秀, 門野岳史, 川上民裕, 久木野竜一, 幸野健, 小寺雅也, 高原正和, 谷岡未樹, 中西健史, 中村泰大, 長谷川稔, 藤本学, 藤原浩, 前川武雄, 松尾光馬, 山崎修, レパヴー・アンドレ, 立花隆夫, 尹浩信 : 日本皮膚科学会ガイドライン 創傷・熱傷ガイドライン委員会報告  熱傷診療ガイドライン 日皮会誌 121 (14): 3279-3306, 2011

著 書
  1. Ogawa H, Ishibashi Y, Kitajima Y, Otsuka F, Hashimoto T, Manabe M eds.: The Color Atlas of Disorders of Keratinization Kyowa Kikaku, Ltd., Tokyo, 2011